Long-Standing Compound May Facilitate Fat Reduction While Preserving Muscle

Buzzline

Researchers at UC Berkeley have identified a compound, known as TOFA, which has been around for decades, that could provide a novel strategy for obesity management. Instead of merely curbing appetite, TOFA enhances energy expenditure in the body. In experiments with mice, this compound resulted in an increase in energy utilization of up to 18%, led to a decrease in body fat with minimal muscle loss, and improved metrics related to blood sugar, triglycerides, and fatty liver conditions. Notably, TOFA's efficacy was amplified when used alongside GLP-1 medications like Ozempic and Wegovy, which are associated with muscle deterioration and nutritional deficits. These significant findings were shared on August 21 in Science Advances. Disclosure: This video contains stock footage and content created or enhanced using AI-assisted tools.  ai-generated

Transcript

00:00Scientists may have found a new way to burn fat without losing muscle, and it's built on a compound that's

00:05been around for decades.

00:07Researchers at UC Berkeley found that a molecule called TOFA increased energy use in mice by as much as 18%,

00:13reducing body fat without any significant loss of muscle.

00:17It also improved blood sugar, triglycerides, and fatty liver disease.

00:21That matters because popular GLP-1 drugs like Ozempic and Wegevy work by cutting appetite, which can sometimes lead to

00:29nutritional deficiencies and muscle loss.

00:31Instead of reducing how much the body eats, TOFA increases how much energy it burns.

00:36The compound produced even stronger results when combined with GLP-1 drugs, and researchers say it could point toward treatments

00:44that deliver fat loss while protecting muscle mass.

00:47Disclosure. This video contains stock footage and content created or enhanced using AI-assisted tools.

Category

Transcript

Comments

Recommended